Is a complete NDRA research report available?

No complete published report is available for ENDRA Life Sciences Inc. (NDRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · USD

$4.69

-0.27 (-5.5%)· Recorded snapshot

Market cap	7M
Net income (ttm)	-5.9M
EPS (ttm)	-$5.38
Shares out	1.5M
Volume	10,125
Beta	-0.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -5.9M
EPS (ttm): -$5.38
Market cap: 7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001681682
Company name	ENDRA Life Sciences Inc.
Country	United States
Country code	US
CUSIP number	29273B500
Earnings date	2026-11-16
Earnings time	bmo
Employees	11
Employees change	-5
Employees growth	-31.25%
Enterprise value	$5.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
Industry	Diagnostics & Research
IPO date	2017-05-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US29273B5003
Last 10-K release date	2026-03-31
Last earnings date	2026-08-17
Last refreshed	2026-10-28
Last stock split date	2024-11-07
Last stock split type	Reverse
Market cap	$7M
Market cap category	Nano-Cap
Next earnings date	2026-11-16
Options	No
Price	$4.69
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	NDRA
U.S. state	Michigan
Website	https://endrainc.com

Metric

Value

Amount currency

USD

CIK code

0001681682

Company name

ENDRA Life Sciences Inc.

Country

United States

Country code

CUSIP number

29273B500

Earnings date

2026-11-16

Earnings time

bmo

Employees

Employees change

-5

Employees growth

-31.25%

Enterprise value

$5.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2007

Industry

Diagnostics & Research

IPO date

2017-05-09

Is primary listing

Yes

Is SPAC

ISIN number

US29273B5003

Last 10-K release date

2026-03-31

Last earnings date

2026-08-17

Last refreshed

2026-10-28

Last stock split date

2024-11-07

Last stock split type

Reverse

Market cap

$7M

Market cap category

Nano-Cap

Next earnings date

2026-11-16

Options

Price

$4.69

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

NDRA

U.S. state

Michigan

Website

https://endrainc.com

Metric	Value
Earnings yield	-114.75%
FCF / EV yield	-78.98%
FCF yield	-65.07%
Industry forward P/E	30.92x
Industry P/E	50.57x
P/B ratio	1.18x
Price / tangible book value	1.18x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-114.75%

FCF / EV yield

-78.98%

FCF yield

-65.07%

Industry forward P/E

30.92x

Industry P/E

50.57x

P/B ratio

1.18x

Price / tangible book value

1.18x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-537,878
Profitable quarters	1
ROA	-77.32%
ROA (5Y)	-86.02%
ROCE	-92.93%
ROE	-152.04%
ROE (5Y)	-199.93%
ROIC	-94.78%

Metric

Value

Profit per employee

$-537,878

Profitable quarters

ROA

-77.32%

ROA (5Y)

-86.02%

ROCE

-92.93%

ROE

-152.04%

ROE (5Y)

-199.93%

ROIC

-94.78%

Metric	Value
EPS growth quarters	2
EPS growth years	6
Net income growth quarters	1
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-18,670
Depreciation and amortization	$38,551
EBIT	$-6.6M
EBITDA	$-6.6M
EPS	$-5.38
FCF per share	$-3.23
Financing cash flow	$8.9M
Free cash flow	$-4.8M
Free cash flow minus SBC	$-6M
Investing cash flow	$-332,895
Net cash flow	$3.7M
Net income	$-5.9M
Operating cash flow minus SBC	$-6M
Operating income	$-6.6M
Stock-based compensation	$1.2M

Metric

Value

Capital expenditures

$-18,670

Depreciation and amortization

$38,551

EBIT

$-6.6M

EBITDA

$-6.6M

EPS

$-5.38

FCF per share

$-3.23

Financing cash flow

$8.9M

Free cash flow

$-4.8M

Free cash flow minus SBC

$-6M

Investing cash flow

$-332,895

Net cash flow

$3.7M

Net income

$-5.9M

Operating cash flow minus SBC

$-6M

Operating income

$-6.6M

Stock-based compensation

$1.2M

Metric	Value
Book value per share	$4.21
Debt / equity	0.07
Long-term assets	$2.4M
Long-term liabilities	$845,936
Net cash (debt)	$1.3M
Net cash / market cap	17.61%
Net cash growth	4.76%
Net debt / equity	-0.21
Piotroski F-Score	2
Property, plant and equipment	$444,255
Shareholders' equity	$6.3M
Tangible book value	$6.3M
Tangible book value per share	$4.21
Total assets	$7.9M
Total cash	$1.7M
Total debt	$429,274
Total liabilities	$1.6M
WACC	3.59%

Metric

Value

Book value per share

$4.21

Debt / equity

0.07

Long-term assets

$2.4M

Long-term liabilities

$845,936

Net cash (debt)

$1.3M

Net cash / market cap

17.61%

Net cash growth

4.76%

Net debt / equity

-0.21

Piotroski F-Score

Property, plant and equipment

$444,255

Shareholders' equity

$6.3M

Tangible book value

$6.3M

Tangible book value per share

$4.21

Total assets

$7.9M

Total cash

$1.7M

Total debt

$429,274

Total liabilities

$1.6M

WACC

3.59%

Metric	Value
Current assets	$5.6M
Current liabilities	$786,578
Current ratio	7.1
Net working capital	$3.2M
Quick ratio	2.21
Working capital	$4.8M

Metric

Value

Current assets

$5.6M

Current liabilities

$786,578

Current ratio

7.1

Net working capital

$3.2M

Quick ratio

2.21

Working capital

$4.8M

Metric	Value
Buyback yield / dilution	-113.32%
Dividend yield	0%
Shareholder yield	-113.32%

Metric

Value

Buyback yield / dilution

-113.32%

Dividend yield

Shareholder yield

-113.32%

Metric	Value
150-day SMA	$5.13
1D price change	-5.46%
1M price change	-22.35%
1M total return	-22.35%
1W price change	0.21%
1W total return	0.21%
1Y price change	-11.51%
1Y return CAGR	-11.52%
1Y total return	-11.51%
20-day SMA	$5.22
200-day SMA	$4.80
3M price change	-1.88%
3M total return	-1.88%
3Y price change	-99.72%
3Y return CAGR	-85.96%
3Y total return	-99.72%
50-day SMA	$5.42
50-day SMA vs 200-day SMA	50over200
52-week high	$6.95
52-week high date	2025-11-17
52-week low	$2.96
52-week low date	2026-03-10
5Y price change	-99.99%
5Y return CAGR	-84.61%
5Y total return	-99.99%
6M price change	-2.7%
6M total return	-2.7%
All-time high	$205,800.21
All-time high date	2017-12-26
All-time low	$2.90
All-time low date	2025-05-09
Average true range (ATR)	$0.41
Average volume	15.1K
Beta (1Y)	3.53
Beta (2Y)	1.7
Beta (5Y)	-0.08
Change from 52-week high	-32.52%
Change from 52-week low	58.45%
Change from all-time high	-100%
Change from all-time low	61.72%
Change from open	-5.44%
Day's gap	-0.02%
Dollar volume	$47,486
High price	$5.10
Low price	$4.56
Monthly RSI	31.7
Open price	$4.96
Position in 52-week range	24.07%
Premarket change	-5.26%
Premarket close	$4.96
Premarket price	$4.70
Previous close	$4.96
Price vs 150-day SMA	-8.51%
Price vs 20-day SMA	-10.22%
Price vs 200-day SMA	-2.35%
Price vs 50-day SMA	-13.53%
Relative volume	0.68
RSI	40.4
Sharpe ratio	0.38
Sharpe ratio (3Y)	-0.39
Sharpe ratio (5Y)	-0.64
Sortino ratio	0.62
Sortino ratio (3Y)	-0.6
Sortino ratio (5Y)	-0.97
Volume	10.1K
Weekly RSI	44.78
YTD price change	3.53%
YTD total return	3.53%

Metric

Value

150-day SMA

$5.13

1D price change

-5.46%

1M price change

-22.35%

1M total return

-22.35%

1W price change

0.21%

1W total return

0.21%

1Y price change

-11.51%

1Y return CAGR

-11.52%

1Y total return

-11.51%

20-day SMA

$5.22

200-day SMA

$4.80

3M price change

-1.88%

3M total return

-1.88%

3Y price change

-99.72%

3Y return CAGR

-85.96%

3Y total return

-99.72%

50-day SMA

$5.42

50-day SMA vs 200-day SMA

50over200

52-week high

$6.95

52-week high date

2025-11-17

52-week low

$2.96

52-week low date

2026-03-10

5Y price change

-99.99%

5Y return CAGR

-84.61%

5Y total return

-99.99%

6M price change

-2.7%

6M total return

-2.7%

All-time high

$205,800.21

All-time high date

2017-12-26

All-time low

$2.90

All-time low date

2025-05-09

Average true range (ATR)

$0.41

Average volume

15.1K

Beta (1Y)

3.53

Beta (2Y)

1.7

Beta (5Y)

-0.08

Change from 52-week high

-32.52%

Change from 52-week low

58.45%

Change from all-time high

-100%

Change from all-time low

61.72%

Change from open

-5.44%

Day's gap

-0.02%

Dollar volume

$47,486

High price

$5.10

Low price

$4.56

Monthly RSI

31.7

Open price

$4.96

Position in 52-week range

24.07%

Premarket change

-5.26%

Premarket close

$4.96

Premarket price

$4.70

Previous close

$4.96

Price vs 150-day SMA

-8.51%

Price vs 20-day SMA

-10.22%

Price vs 200-day SMA

-2.35%

Price vs 50-day SMA

-13.53%

Relative volume

0.68

RSI

40.4

Sharpe ratio

0.38

Sharpe ratio (3Y)

-0.39

Sharpe ratio (5Y)

-0.64

Sortino ratio

0.62

Sortino ratio (3Y)

-0.6

Sortino ratio (5Y)

-0.97

Volume

10.1K

Weekly RSI

44.78

YTD price change

3.53%

YTD total return

3.53%

Metric	Value
Float	1.4M
Float percentage	90.82%
Shares change (QoQ)	106.34%
Shares change (YoY)	113.32%
Shares held by insiders	4.73%
Shares held by institutions	10.24%
Shares outstanding	1.5M
Short % of float	1.77%
Short % of shares	1.61%
Short ratio	0.5 days

Metric

Value

Float

1.4M

Float percentage

90.82%

Shares change (QoQ)

106.34%

Shares change (YoY)

113.32%

Shares held by insiders

4.73%

Shares held by institutions

10.24%

Shares outstanding

1.5M

Short % of float

1.77%

Short % of shares

1.61%

Short ratio

0.5 days

ENDRA Life Sciences Inc. (NDRA)

Price

Financial snapshot

Fair-value bridge

Latest news · NDRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NDRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NDRA

Frequently asked questions